Stock MLTX MOONLAKE IMMUNOTHERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart MoonLake Immunotherapeutics

Equities

MLTX

KY61559X1045

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
39.91 USD +2.25% Intraday chart for MoonLake Immunotherapeutics -1.92% -33.91%
May. 07 MoonLake Immunotherapeutics Q1 Net Loss Widens MT
May. 07 MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
MOONLAKE IMMUNOTHERAPEUTICS Stock MoonLake Immunotherapeutics
 2.51B - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.69B -
ARGENX SE Stock argenx SE
 21.97B -
GENMAB A/S Stock Genmab A/S
 19.27B
  1. Stock Market
  2. Equities
  3. MLTX Stock
  4. Charts MoonLake Immunotherapeutics
  5. Sector Chart